Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.

The American journal of psychiatry - 1 May 2017

Marshe Victoria S, Maciukiewicz Malgorzata, Rej Soham, Tiwari Arun K, Sibille Etienne, Blumberger Daniel M, Karp Jordan F, Lenze Eric J, Reynolds Charles F, Kennedy James L, Mulsant Benoit H, Müller Daniel J

Abstract excerpt

OBJECTIVE: The primary objective of this study was to investigate five putatively functional variants of the norepinephrine transporter (SLC6A2, NET) and serotonin transporter (SLC6A4, SERT) genes and remission in depressed older adults treated with venlafaxine. A secondary objective was to analyze 17 other variants in serotonergic system genes (HTR1A, HTR2A, HTR1B, HTR2C, TPH1, TPH2) potentially involved in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Depressive Disorder, Major
Share to Likelihood Functions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Norepinephrine Plasma Membrane Transport Proteins

Share to Psychiatric Status Rating Scales

Share to Psychometrics

Share to Quantitative Trait Loci

Share to Treatment Outcome

Share to Venlafaxine Hydrochloride

Source

Identifiers

PMID: 28068779
DOI: 10.1176/appi.ajp.2016.16050617

Genes

TPH1
TPH2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.PMID 28068779Read ↗

SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population.Semantic proximity Read ↗

No Association Between SLC6A4 Gene Polymorphisms With Treatment Remission to Venlafaxine in Han Chinese Depressive Patients.Semantic proximity Read ↗

SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcome.Semantic proximity Read ↗

No association between CYP2C19 genetic polymorphism with treatment remission to antidepressant venlafaxine in Han Chinese population.Semantic proximity Read ↗

A novel NR3C2 polymorphism and the increased thyroid-stimulating hormone concentration are associated with venlafaxine treatment outcome in Chinese Han MDD patients.Semantic proximity Read ↗

Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.Semantic proximity Read ↗

The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings.Semantic proximity Read ↗

Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder.Semantic proximity Read ↗

A Prospective Study of Serotonin and Norepinephrine Transporter Genes and the Response to Desvenlafaxine Over 8 Weeks in Major Depressive Disorder.Semantic proximity Read ↗

Catechol-O-methyltransferase genotype as modifier of superior responses to venlafaxine treatment in major depressive disorder.Semantic proximity Read ↗

Pharmacogenetics of venlafaxine response in older adults with depression and chronic lower back pain.Semantic proximity Read ↗

Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.